Talaji, Roaida E.

HRN: 11-08-30  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/06/2025
CEFTRIAXONE 1G (VIAL)
08/06/2025
08/13/2025
IV
2g
OD
CAP-MR
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: